Compare stocks

NanoRepro AG is a German company operating in the healthcare industry, specializing in the development and distribution of diagnostic rapid tests. The company offers a range of products primarily focused on fertility, infectious diseases, and preventive care, providing over-the-counter solutions that cater to both professional and consumer markets. Founded in 2002, NanoRepro is headquartered in Marburg, Germany. The company leverages a network of distribution partners to enhance its market presence across various countries, reflecting a strategic focus on expanding its geographical footprint. NanoRepro's competitive strength lies in its emphasis on research and development, supporting its capability to introduce innovative diagnostic solutions.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.